Malaria is transmitted by the female anopheles mosquito. Today malaria affects more than 2400 million
people, over 40% of the world's population, in more than 100 countries
in the tropics. Every year 300 million to 500 million people suffer
from this disease and about 1.5 million to 3 million people die of
malaria every year (85% of these occur in Africa), accounting for about
4-5% of all fatalities in the world. Malaria ranks third among the major infectious diseases in causing deaths. Malaria is caused by the parasite called Plasmodia. There are four identified species of this parasite causing human malaria, namely, Plasmodium vivax, P. falciparum, P. ovale and P. malariae. Plasmodium falciparum is more common in sub Saharan Africa and Melanesia (Papua New Guinea, Solomon Islands); Plasmodium vivax in Central and South America, India, N. Africa and Middle East; Plasmodium ovale in Western Africa and Plasmodium malariae is sporadic worldwide. Symptoms The symptoms appear after 7-15 days of an infected bite. Typical malarial illness is characterized by shaking chills, followed by high grade fever and sweating (Cold stage, Hot stage and Sweating stage), usually occurring during mid-day. This recurs in 48-72 hour cycles. But many patients may have atypical illness characterised by atypical fever, head ache and body ache, weakness, prostration, easy fatiguability, Vomiting, diarrhoea, cough etc. With complicated malaria, patients can develop breathlessness, chest pain, abdominal pain, altered behaviour, altered sensorium, convulsions, coma etc. Diagnosis Diagnosis of malaria is confirmed by examination of the blood for malarial parasite, either by a peripheral smear examination or the new QBC fluorescent technique. Now, non-microscopic rapid tests are also available. Treatment Chloroquine is the most widely used drug for treating P. vivax malaria. With wide spread resistance to chloroquine in P. falciparum malaria, combinations of drugs like artimisinin derivatives, sulfadoxine/pyrimethamine, doxycycline, lumefantrine, atovaquone and proguanil etc., are being used for the treatment of P. falciparum infection. Prevention Malaria vaccine has not yet become a reality and therefore, prevention of individual is essentially protection from the vector mosquitoes. Measures for Effective Control EffortsUnless breeding sites (most of which are man-made and temporary) are taken care of, it is impossible to control mosquito breeding and hence mosquito-borne diseases. And it is impossible to achieve this without the participation of the general public. Education of the people is thus very important for any meaningful action. The following measures are called for to minimize mosquito breeding and these measures require only a trifle of human efforts:
|
